Torrent Pharmaceuticals, is in talks to acquire the dermatology business of Mumbai-headquartered Encore group. The acquisition value of the dermatology business is around Rs 350 crore.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments